Meta Study
No news here - we have known for ages that Pelareorep is a dud in many indications and with many drug combinations.
But it is interesting timing for this Meta Study to appear. There must be some underlying reason for people to waste time publishing old news.
It certainly does little to instill confidence in the promised breast cancer phase 3. I'll be very suprised if that ever gets launced.
Really, the last kick at the can after 20+ years of failed results is now ESMO and PanCAN.
I think ONC should fire 90% of their staff, reduce expenses by half and hold tight till the first pancreatic data comes out in about three years.